Litcius/Paper detail

Methylprednisolone Versus Dexamethasone in COVID-19: A Meta-Analysis of Nonrandomized Studies

Azizullah Beran, Hazem Ayesh, Mohammed Mhanna, Omar Srour, Rami Musallam, Wasef Sayeh, Waleed Khokher, Nehaya Altorok, Zaid Noori, Ragheb Assaly, Nezam Altorok

2022American Journal of Therapeutics13 citationsDOI

Abstract

Beran, Azizullah MD; Ayesh, Hazem MD; Mhanna, Mohammed MD; Srour, Omar MD; Musallam, Rami MD; Sayeh, Wasef MD; Khokher, Waleed MD; Altorok, Nehaya MD; Noori, Zaid MD; Assaly, Ragheb MD; Altorok, Nezam MD Author Information

Topics & Concepts

MedicineDexamethasoneCoronavirus disease 2019 (COVID-19)Methylprednisolone2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MEDLINEMeta-analysisBetacoronavirusInternal medicinePharmacologyVirologyOutbreakLawPolitical scienceDiseaseInfectious disease (medical specialty)COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Hematological disorders and diagnostics
Methylprednisolone Versus Dexamethasone in COVID-19: A Meta-Analysis of Nonrandomized Studies | Litcius